Therapeutics News

The use of intravenous antibiotics, specifically ertapenem, was associated with improvement in inflammatory markers in patients with hidradenitis suppurativa, according to a study.

The FDA’s broad indication for the use of beremagene geperpavec therapy for the treatment of dystrophic epidermolysis bullosa may have large financial implications for payers, according to a study.

Patients with plaque or guttate psoriasis treated with at-home phototherapy experienced similar benefits to those treated in-office, according to topline study data.

Ophthalmic application of beremagene geperpavec was successful in treating recurrent cicatrizing conjunctivitis in one patient with dystrophic epidermolysis bullosa, according to a study.

It was just another day at school when sophomore Cole Villaflor and his classmates were asked to write on-demand essays in class. As he approached this seemingly easy assignment, his hands began to sweat, dampening the page.

Almirall has entered into an exclusive license agreement with Novo Nordisk to develop and commercialize NN-8828 for autoimmune and inflammatory dermatological diseases, according to a company press release.

Janus kinase inhibitor therapy in short durations did not significantly increase the risk for major adverse cardiovascular events or venous thromboembolism in patients with low cardiovascular risk profiles, according to a study.

Aurlumyn injection has been approved for the treatment of severe frostbite in adults to reduce the risk of finger or toe amputation, the FDA announced in a press release.

MIAMI BEACH, Fla. — Patients who are elderly or are poor candidates for surgery with nonmelanoma skin cancer would benefit from superficial radiation therapy, according to a speaker at South Beach Symposium.

MIAMI BEACH, Fla. — Pediatric dermatologists should be open with patients and families when discussing boxed warnings while emphasizing that the benefits outweigh the risks, according to a speaker here.